# A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults

> **NCT06360640** · PHASE1 · COMPLETED · sponsor: **AdjuTec Pharma AS** · enrollment: 46 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** APC148 and Placebo

## Key facts

- **NCT ID:** NCT06360640
- **Lead sponsor:** AdjuTec Pharma AS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-02
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-03-10
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360640, "A First-in-human Trial to Evaluate Safety, Tolerability, and Pharmacokinetics of APC148 in Healthy Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06360640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*